
Andorra: CBD and cannabis regulation, March 2023
24th March 2023 - Regulatory reports |
This report provides a summary of the current regulatory framework in place for CBD, hemp and cannabis in Andorra
This report provides a summary of the current regulatory framework in place for CBD, hemp and cannabis in Andorra
A hemp industry under threat, a recreational cannabis market in limbo, and an uncertain political climate have left the future of cannabis in Virginia unclear and many grappling with the fallout of recent legal activity
This report provides a comprehensive overview of the current regulatory framework in place for CBD, cannabis and other cannabinoids, covering everything from cultivation and processing to finished products and import/export
National Assembly member Christophe Bex hopes to spearhead efforts to legalise cannabis in France and could draft legislation aimed at doing just that
US cannabis company Trulieve surpassed $1bn in revenue last year, it announced during the release of its 2022 fourth-quarter and full-year results
This report offers a comprehensive overview of the current regulatory framework in place in Peru for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
US-based 22nd Century’s cannabinoid division saw 19% quarterly revenue growth in the fourth quarter of 2022 despite a November fire disrupting operations at a California facility
Canadian cannabis producer Cronos Group saw overall reduced losses for the year, with results helped by sales growth in Canada and Israel but hindered by lower sales in the US
The march to recreational cannabis legalisation in the US is by no means a straight line upwards, as the recent ballot result in Oklahoma shows
Kanavape founder Sebastien Beguerie talks with CannIntelligence podcast host Tiziana Cauli about his judicial battle leading to a crucial European Court of Justice ruling which established CBD legal status across Europe
US cannabis company Unrivaled Brands recorded a positive performance in 2022 and plans to expand its cannabis retail footprint across its home state of California
Tamarind Intelligence data continues to be an invaluable tool used by governments and NGOs around the world, contributing to a wide number of government and supra-national projects
This report provides a detailed overview of the current regulatory framework in place in Portugal for hemp, cannabis and other cannabinoids, covering all policy areas
CannIntelligence’s global regulatory tracker for recreational cannabis, updated quarterly, provides a comprehensive overview of recreational cannabis regulations in 75 countries across the globe
Another poll weighted to be nationally representative of US voters has shown strong support for legalising adult use of recreational cannabis – and broad backing for including social equity measures
An expert working group preparing an outline proposal for the regulation of the recreational cannabis market in the Czech Republic has released a provisional set of recommendations
Recent criticism from the Swiss canton of Bern on a pilot study to legalise and sell recreational cannabis in pharmacies will have no impact on plans to carry on with the project
Amid increased criticism, members of Costa Rica’s presidential ministry will modify elements of its recreational cannabis bill prior to seeking its advancement in the country’s 57-member Legislative Assembly
Mexican CBD shop Paradise says it has placed itself in prime position for the creation of a legal recreational cannabis market in the country
This report provides a detailed overview of the current regulatory framework in place for CBD and other cannabinoids, hemp and cannabis
While youth cannabis use is increasing in the US, contextual data show this trend is not associated with the creation of legal cannabis markets
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.